ABSTRACT In an attempt to improve methods of determining the site of airway narrowing we have tried using a heavier than air gas mixture (SF6/02) in addition to the more widely used lighter than air gas mixture (HeJO2). Response to varying inspired gas density has been assessed by means ofchange in mean transit time (MTT) as well as by means of change in flow rate at 50% of vital capacity (Vmax5o).
Much of the clinical practice of respiratory medicine is concerned with patients with airway narrowing, and knowledge of the site of this narrowing within the airways may be helpful in understanding the pathogenesis of disease and in directing therapeutic efforts. However, methods of determining the major site of narrowing within the airways are imperfect. Measurement of airways resistance may reflect large airway calibre in normal subjects but in a patient with abnormal airways resistance it is impossible to say whether this is the result of a relatively small change in calibre of the large airways or a relatively large change in calibre of the small airways. Frequency dependence of compliance may be a good detector of inequal time constants in patients with minor degrees of peripheral airways disease but the technique is difficult to perform and poorly reproducible.' Measurement of closing volume is useful in detecting isolated peripheral airway disease but once conventional tests of airway function become abnormal the gradient of phase 3 becomes much steeper and the closing volume is often not discernible. Bronchography has shown the site of antigeninduced airway narrowing in dogs2 but is an impractical method for widespread use in patients. While newly described radioaerosol and isotope imaging techniques3 show promise as methods of distinguishing between central and peripheral airway narrowing, the most common accepted method is that of air and helium/oxygen (He/02) flow volume curves, 4 5 and their theoretical background is supported by validation in dogs. 6 Unfortunately, reproducibility of response of flow rates at 50% of vital capacity (Vmax50) to He/02 breathing compares poorly with other standard physiological measurements.7 8 Furthermore the test is defining small airways as airways in which a laminar flow regime predominates and these may not correspond with the anatomical small airways (those with an internal diameter of less than 2 mm), nor with the small airways detected by closing volume measurement (which are those which close on expiration), nor with the "small airways" in the sense of airways peripheral to the equal pressure point.9 Mink number. Derivatives of the second moment of the flow-time curve have also been suggested as a method of determining the site of airway narrowing. '3 14 In this study, therefore, we have attempted to assess the advantages of additional use of a denser than air gas mixture, sulphur hexafluoride/oxygen (SF6/02), and the value of assessing response to helium/oxygen (He/02) breathing by measurement of MTT rather than Vmax5o. We have also compared second moment derivatives with He/02 responsiveness offlow rates at 50 % of vital capacity.
Methods
Ten normal subjects (non-smokers, seven men and three women, mean age 32-9 years) and 16 patients with symptomatic asthma took part in the study. Flow-volume curves were obtained using an Ohio 840 electronic spirometer from which flow and volume signals were taken to an Electronics for Medicine DR8 photographic recorder. From the spirometer, flow and volume signals were also taken to a multi-channel recorder allowing simultaneous recording of flow-time and volume-time curves. The participants performed a minimum of three forced expirations breathing air and results were accepted only if the vital capacity was reproducible to within 100 ml. Three further forced expirations were then performed after breathing He/02 (80 %/20 %) until end-tidal nitrogen concentration was less than 5 For convenience the latter will subsequently be referred to as "Brooks factor". Flow rates every tenth of a second were measured manually from the flow-time curve, punched onto computer cards, and analysed as shown in the appendix to provide (1) mean transit time (MTT), which is derived from the first moment about the origin of the flow-time curve, and which indicates the average time taken by gas molecules in the lung to reach the mouth; and (2) the coefficient of variance (COV) which is derived from the second moment about the mean transit time and equals the standard deviation MTT The COV indicates the spread or variation of transit times between the initial part of the vital capacity, which is expired quickly, and the slower terminal portion of the vital capacity. The effect of He/02 breathing upon MTT was assessed in the same manner as for Vmax5o.
Six of the patients had repeated measurements at different times with different degrees of airways obstruction and five of the normal subjects had measurements repeated at monthly intervals for three months to assess reproducibility. This was assessed within session and between session by means of the coefficient of variability (SD x 100%
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Results
The table shows the results for normal subjects when breathing air, He/02, and SF6/02 mixtures as assessed by flow rates measured from the flow-volume curve and by MTT and COV. As a group the patients with asthma had longer mean transit times breathing air (mean for 16 patients= 1-325) and increased values for COV (Mean= 1 191) whencomparedwith the normal subjects. Figure 1 shows a comparison of the response of flow rates at 50% VC to breathing He/02 (compared with air) with that to breathing SF6/02 (compared with air). Results are included from 10 normal subjects studied on 20 occasions and the 16 patients with asthma studied on 26 occasions. Figure 2 shows the percentage increase in Vmax50 breathing He/02 compared with air, plotted against the percentage shortening of MTT achieved by breathing the same mixture, again for normal subjects and patients with asthma.
The correlation coefficient (r) between these two variables for normal subjects was 0-82 (p<0-001, slope= -0 46, intercept= -1 35), for the asthmatic patients and normal subjects together r= 0-61. (p<0-001, slope= -0-36 intercept= -5-45) and asthmatic patients alone r = 0 56 (p < 0-01, slope = -0 34, intercept= -6 07). The weaker correlation among the patients with asthma was largely accounted for by the five "aberrant" results discussed below.
From fig 2 it can be seen that all the normal subjects and most all the patients were "responders" to He/02 breathing and a smaller number nonresponders by both methods. One patient who was studied soon after admission to hospital with acute asthma, showed a response to He/02 breathing as tChange compared with value breathing air statistically significant: p < 0-001 paired t test. 15 The reproducibility of flow rates on SF6/02 within session for normal subjects and patients was good and similar to that for He/02 even at monthly intervals. However the coefficient of variation of percentage change in flow rates on SF6/02 compared to air was better than that of He/02 (5 7% vs 22 5%) and hence when results were expressed as Brooks factor" the coefficient of variability was similarly better (14-0%) than that for the helium-air density dependence (22-5 %).
Thus far the use of SF6/02 appeared promising. However, when the effect of SF6/02 on Vmax5o in normal subjects and in patients with asthma was compared with the effect of He/02 there was no correlation (fig 1) . With He/02 there was marked interindividual variability as one would expect if the group.bmj.com on April 9, 2017 -Published by http://thorax.bmj.com/ Downloaded from major site of airflow limitation was differing between subjects. However, the response to SF6/02 breathing was more uniform and those who had not altered their flow rates on He/02 usually did so on SF6/02.
The reason for this lack of correlation is not clear but it is likely that the greater difference in density between air and SF6 than that between air and helium'6 disguises real differences between individuals. In those who were responders to He/02 breathing because of the greater difference in density between air and SF6, flows are reduced more by SF6 than they are increased by helium. The fact that the reduction in flow rates on SF6/02 was consistent despite variations in response to He/02 is in part because a 50 % increase in flow is not one of the same absolute magnitude as a 500% reduction, and in part because there is a more obvious endpoint to a reduction in flow than there is hypothetically to an increase in flow. If this explanation is correct it must also explain why some non-responders to He/02 breathing reduced their flow rates on SF6/02. In these patients most of upstream resistance9 originates in airways in which a laminar flow regime independent of density predominates.4 However, even in such situations upstream resistance may include a component from airways with turbulent flow and even in the predominantly laminar flow airways some eddying occurs at bifurcations. Thus changes in density can presumably have some effect, which is not great when a moderate change in density is made (ie He/02 given), but becomes apparent when a large change in density of inspired gas is made.
It is possible that a lesser increase in density than that of 70% SF6/30% 02 may produce a change more comparable to that of He/02 (eg 40% SF6, 40% N2, 20% 02). This requires study but it is possible that the single advantage of SF6 shown by these studies (that of better reproducibility) may then be lost, for this reduction in inter and intraindividual variability may be caused entirely by the overpowering effect of the very dense SF6. Either way in these studies the SF6/02 response did not correlate with that to He/02 and did not distinguish normal subjects from any patients with asthma. When comparing flow rates breathing air with those breathing He/02 no consistent differences in response have been shown between results obtained at the same time from exhaled flow-volume curves and those obtained in a plethysmograph. 17 However when comparing flow rate response to He/02 breathing at different times or after drugs when there may be significant changes in vital capacity, Vmax50 may be difficult to interpret if absolute lung volumes are not measured. Under such circumstances although flow rates at 50 % of exhaled VC are being compared each time, because of changes in residual M R Partridge, A C Watson, and K B Saunders volume and total lung capacity the absolute lung volume at which measurements are being made may well be different. Theoretically this source of error can only be overcome by the use of a Mead type plethysmograph,'8 but serial studies in a plethysmograph-for example, after exercise,-are often impractical. While mean transit time is also derived from an exhaled vital capacity and like the exhaled flow volume curve takes no account of thoracic gas compression or changes in residual volume, it does have the advantage that it is reflecting emptying characteristics of a much greater lung volume rather thanjust the flow rate at one lungvolume (egVmax5o).
Hypothetically, assessment of response to He/02 breathing by means of MTT analysis, therefore, has advantages over assessment by means of change in flow rates at 50 % of exhaled VC.
While standard equations were used, the method of calculation of moments used in this study differs from that used by others,13 14 19 20 being based on the flow-time curve rather than the volume-time curve. This was because we had no online computer and preliminary studies showed that it was easier manually to digitise the flow-time curve than the volume-time curve. Our method produced results for derivatives of moment analysis which were almost identical to those found in normal subjects by others. '9 20 The results show that there was a statistically significant correlation between the effect of He/02 breathing upon MTT and its effect upon Vmax5o in both normal subjects and in patients with asthma ( fig 2) . A few aberrant results were shown but as explained it is possible that these were related to the difficulties of measurement 
